The investment seeks long-term growth of capital... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ForeignLargeGrowth
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TRSLX | 6.47 | N/A | N/A |
| Transamerica Small Cap Value R | |||
| PICEX | 6.86 | N/A | N/A |
| Virtus SGA Emerging Markets Equity C | |||
| SEEIX | 14.52 | N/A | N/A |
| SEI International Equity I (SIT) | |||
| FTDZX | 212.97 | N/A | N/A |
| Franklin Biotechnology Discovery Adv | |||
| DFCEX | 33.36 | -0.99 | -2.88% |
| DFA Emerging Markets Core Equity 2 I | |||
A.I.dvisor indicates that over the last year, CNPCX has been closely correlated with RPEBX. These tickers have moved in lockstep 100% of the time. This A.I.-generated data suggests there is a high statistical probability that if CNPCX jumps, then RPEBX could also see price increases.
| Ticker / NAME | Correlation To CNPCX | 1D Price Change % | ||
|---|---|---|---|---|
| CNPCX | 100% | -1.33% | ||
| RPEBX - CNPCX | 100% Closely correlated | -1.33% | ||
| RNPAX - CNPCX | 100% Closely correlated | -1.33% | ||
| CNPEX - CNPCX | 100% Closely correlated | -1.32% | ||
| RNPBX - CNPCX | 100% Closely correlated | -1.34% | ||
| RNPCX - CNPCX | 100% Closely correlated | -1.32% | ||
More | ||||